ロード中...
Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
BACKGROUND: Although almost a year has passed since the Coronavirus disease 2019 (COVID-19) outbreak and promising reports of vaccines have been presented, we still have a long way until these measures are available for all. Furthermore, the most appropriate corticosteroid and dose in the treatment...
保存先:
| 出版年: | BMC Infect Dis |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8035859/ https://ncbi.nlm.nih.gov/pubmed/33838657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-021-06045-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|